Therefore, we conclude that FBXO22 upregulates the expression of FOXM1 and FOXM1 directly binds to the Rad51 promoter to transactivate Rad51, which ultimately leads to lung cancer radioresistance. The gene discussed is FBXO22; the disease is lung cancer.